TrinityBridge Ltd Invests $182.44 Million in ChronoScale Corporation Common Stock $CHRN

TrinityBridge Ltd acquired a new stake in shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) in the second quarter, Holdings Channel.com reports. The firm acquired 483,551 shares of the company’s stock, valued at approximately $182,441,000. ChronoScale Corporation Common Stock makes up about 4.9% of TrinityBridge Ltd’s investment portfolio, making the stock its 6th largest position. TrinityBridge Ltd owned 0.14% of ChronoScale Corporation Common Stock as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. Citadel Advisors LLC bought a new position in ChronoScale Corporation Common Stock during the third quarter valued at about $198,000. Geode Capital Management LLC raised its holdings in ChronoScale Corporation Common Stock by 68.9% in the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after acquiring an additional 10,281 shares in the last quarter. J.Safra Asset Management Corp bought a new stake in shares of ChronoScale Corporation Common Stock in the 2nd quarter worth approximately $1,085,000. Shay Capital LLC bought a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter worth approximately $67,000. Finally, Virtu Financial LLC acquired a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth approximately $57,000. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Stock Performance

CHRN opened at $24.10 on Friday. The stock has a market cap of $85.80 million, a PE ratio of -4.48 and a beta of 1.00. The company has a current ratio of 1.55, a quick ratio of 1.03 and a debt-to-equity ratio of 0.25. ChronoScale Corporation Common Stock has a 1 year low of $3.23 and a 1 year high of $30.00. The stock’s 50 day simple moving average is $21.82 and its 200-day simple moving average is $15.69.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its earnings results on Tuesday, June 30th. The company reported ($3.89) EPS for the quarter. The firm had revenue of $18.09 million during the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. Sell-side analysts forecast that ChronoScale Corporation Common Stock will post -0.1 EPS for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.